Long-Term Effect of Dupilumab With Concomitant Topical Corticosteroids on POEM in Adults With Moderate-to-Severe Atopic Dermatitis: LIBERTY AD CHRONOS Trial

Topical Corticosteroids ◽

Abstract not available.

15416 Long-term effect of dupilumab with concomitant topical corticosteroids on the Patient-Oriented Eczema Measure in Adults with moderate to severe atopic dermatitis: LIBERTY AD CHRONOS trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.689 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB150

Author(s):

Jonathan I. Silverberg ◽

Benjamin Lockshin ◽

Melinda Gooderham ◽

Zhen Chen ◽

Abhijit Gadkari ◽

...

Keyword(s):

Atopic Dermatitis ◽

Term Effect ◽

Topical Corticosteroids ◽

Long‐term effect of methotrexate for childhood atopic dermatitis

Journal of Paediatrics and Child Health ◽

10.1111/jpc.14478 ◽

2019 ◽

Vol 55 (12) ◽

pp. 1487-1491 ◽

Cited By ~ 6

Author(s):

Diana Purvis ◽

Martin Lee ◽

Karen Agnew ◽

Nick Birchall ◽

Stuart R Dalziel

Keyword(s):

Atopic Dermatitis ◽

Term Effect ◽

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

The Lancet ◽

10.1016/s0140-6736(17)31191-1 ◽

2017 ◽

Vol 389 (10086) ◽

pp. 2287-2303 ◽

Cited By ~ 364

Author(s):

Andrew Blauvelt ◽

Marjolein de Bruin-Weller ◽

Melinda Gooderham ◽

Jennifer C Cather ◽

Jamie Weisman ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids ◽

Double Blinded ◽

Long-term Effect of “Skin Care School” Program for Childhood Atopic Dermatitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2008.12.146 ◽

2009 ◽

Vol 123 (2) ◽

pp. S46-S46

Author(s):

M. Futamura ◽

K. Otsuji ◽

M. Hirayama ◽

K. Ito ◽

K. Hayashi ◽

...

Keyword(s):

Atopic Dermatitis ◽

Skin Care ◽

Term Effect ◽

School Program ◽

Faculty Opinions recommendation of Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727591680.793534051 ◽

2017 ◽

Author(s):

Hidehisa Saeki

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids ◽

Double Blinded ◽

Long‐term management of moderate‐to‐severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal

British Journal of Dermatology ◽

10.1111/bjd.16520 ◽

2018 ◽

Vol 178 (4) ◽

Author(s):

J. Thomson ◽

A.G.H. Wernham ◽

H.C. Williams

Keyword(s):

Atopic Dermatitis ◽

Critical Appraisal ◽

Topical Corticosteroids ◽

Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: A meta-analysis

Journal of Dermatological Treatment ◽

10.3109/09546634.2015.1027168 ◽

2015 ◽

Vol 26 (6) ◽

pp. 537-540 ◽

Cited By ~ 15

Author(s):

Lei Cao ◽

Lei Wang ◽

Lijia Yang ◽

Shiqin Tao ◽

Rushan Xia ◽

...

Keyword(s):

Atopic Dermatitis ◽

Early Life ◽

Meta Analysis ◽

Term Effect ◽

Long‐term management of moderate‐to‐severe atopic dermatitis with dupilumab and concomitant topical corticosteroids ( LIBERTY AD CHRONOS ): a critical appraisal

British Journal of Dermatology ◽

10.1111/bjd.16317 ◽

2018 ◽

Vol 178 (4) ◽

pp. 897-902 ◽

Cited By ~ 8

Author(s):

J. Thomson ◽

A.G.H. Wernham ◽

H.C. Williams

Keyword(s):

Atopic Dermatitis ◽

Critical Appraisal ◽

Topical Corticosteroids ◽

Faculty Opinions recommendation of Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727591680.793555533 ◽

2019 ◽

Author(s):

Carsten Flohr

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids ◽

Double Blinded ◽

P67: LONG-TERM MANAGEMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB AND CONCOMITANT TOPICAL CORTICOSTEROIDS: A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL (CHRONOS)

Internal Medicine Journal ◽

10.1111/imj.67_13578 ◽

2017 ◽

Vol 47 ◽

pp. 25-25 ◽

Cited By ~ 5

Author(s):

A Blauvelt ◽

M Gooderham ◽

P Foley ◽

Griffiths CEM ◽

JC Cather ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids ◽